You just read:

Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus

News provided by

Anthera Pharmaceuticals, Inc.

Feb 10, 2015, 08:45 ET